学術情報 -BVUT-

BVUTは泌尿器領域の最新情報をお届けすることを目的とし,以下の英文誌より編集委員が医学的かつ科学的に公平な立場から選択した論文のアブストラクトを日本語でご紹介する刊行物です:
BJU International, International Journal of Urology, LUTS: Lower Urinary Tract Symptoms, Neurourology and Urodynamics

注意:一部の文献情報には,日本国内での承認外の内容が含まれている場合があります。薬剤の使用にあたっては,各薬剤の添付文書をご参照ください。

2019年02月号 Vol.1 No.5 February 2019

Vol.1 No.5 February 2019

掲載記事を一括で閲覧いただけます。

移植前のdefunctionalized bladder―過大評価された病態か

Pretransplant defunctionalized bladder—overrated condition?

過活動膀胱患者に対する仙骨神経刺激療法に関する大規模前向き試験:ベースラインの症状の重症度と治療成功率

Baseline symptom severity and therapeutic success in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients

女性の尿道長の人口統計学的特徴

Demographic features of female urethra length

高解像度マノメトリーにより評価した女性の尿禁制メカニズム:尿道注入療法と中部尿道スリング術の比較

The female continence mechanism measured by high resolution manometry: Urethral bulking versus midurethral sling

術前化学療法後の根治的膀胱全摘除術の最適な時期の決定

Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy

前立腺肥大症に対する前立腺動脈塞栓術の有効性と安全性:観察研究およびプロペンシティスコアマッチングによる経尿道的前立腺切除術との比較(UK-ROPE試験)

Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study)

日本人過活動膀胱患者における新規β 3 アドレナリン受容体作動薬ビベグロンの長期安全性および有効性:第III相前向き試験

Long-term safety and efficacy of the novel β 3 -adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study

経尿道的結石破砕術後の短期間の尿管外ステント留置はルーチンのダブルJステント留置よりも有効性が有意に高い:前向き無作為化試験-Fast track stent study(FaST)

Short-term external ureter stenting shows significant benefit in comparison to routine double-J stent placement after ureterorenoscopic stone extraction: A prospective randomized trial – the Fast track stent study (FaST)

The content of this publication contains abstracts and/or translated articles from BJU International, International Journal of Urology, LUTS: Lower Urinary Tract Symptoms, Neurourology and Urodynamics. This material is published by Wiley Publishing Japan K.K. with the permission of the copyright owners. The copyright owners take no responsibility for the accuracy of the translation from the published English original and is not liable for any errors which may occur.

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the copyright owners. This material is supported by an educational grant from Kyorin Pharmaceutical Co., Ltd. for the purpose of furthering medical education in Japan.

Japanese edition 2018
ISSN 2433-9113
© 2018 Wiley Publishing Japan K.K.
Tokyo Office: Koishikawa Sakura Bldg. 4F, 1-28-1 Koishikawa, Bunkyo-ku, Tokyo 112-0002, Japan
Telephone: 81-3-3830-1221 Fax: 81-3-5689-7276
Internet site: http://www.wiley.com/wiley-blackwell
e-mail: ProductionJapan@wiley.com
Associate Commercial Director: Kimiyoshi Ishibashi
Project Team Manager: Shintaro Ashika
Project Manager: Ayumi Kasahara / Naoki Ohishi